The second of a 5-part webinar series examining value assessment in the COVID-19 era hosted by ISPOR and the Innovation and Value Initiative (IVI) will explore whether the methods on which health economists have relied are up to the task or in need of improvement for the pandemic era.
The second of a 5-part webinar series examining value assessment in the COVID-19 era hosted by ISPOR and the Innovation and Value Initiative (IVI) will explore whether the methods on which health economists have relied are up to the task or in need of improvement for the pandemic era.
Moderated by Lou Garrison, PhD; University of Washington, panelists Charles Phelps, PhD; University of Rochester; Anirban Basu, PhD; University of Washington; Susan Griffin, PhD; University of York; and Dan Ollendorf, PhD; Tufts Medical Center will discuss what changes in value assessment methods may be needed to assess value among rapidly developing interventions, including vaccines, treatments, tests, and non-medical care.
“Our webinar series looks at value assessment through today’s pandemic lens to explore how it can be improved to meet the moment,” says Jennifer Bright, executive director, IVI. “This is an incredibly important and relevant discussion for all healthcare decision makers.”
The webinar will be from 1:00 PM -2:15 PM EST on Thursday, August 27. Register for the webinar by clicking here www.ispor.org/webinars-COVID-IVI.Space is limited, so register today!
Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers
November 13th 2024Employees living with diabetes often face unique challenges, such as managing blood sugar levels, balancing medication, and preventing complications, all while maintaining their professional responsibilities. This condition can lead to increased absenteeism, reduced productivity, and rising health care costs.
Read More